Repare Therapeutics Inc

NASDAQ:RPTX  
30.00
-0.39 (-1.28%)
Earnings Announcements

Repare Therapeutics Reports Third Quarter 2020 Financial Results And Operational Highlights

Published: 11/11/2020 21:31 GMT
(RPTX) - Repare Therapeutics Reports Third Quarter 2020 Financial Results and Operational Highlights.
Q3 Loss per Share $0.37.
Q3 Earnings per Share Estimate $-0.38 -- Refinitiv Ibes Data (analyst estimates).
Cash and Restricted Cash As of September 30, 2020 Were $348.1 Million.
Revenue is expected to be $1.25 Million
Adjusted EPS is expected to be -$0.40

Next Quarter Revenue Guidance is expected to be $0.83 Million
Next Quarter EPS Guidance is expected to be -$0.45

More details on our Analysts Page.